Particulate Identification and Assessment Policy

Particulate Identification and Assessment Policy: Training Module

1. LEARNING OBJECTIVES

In the high-stakes environment of sterile pharmaceutical manufacturing, workforce readiness is built upon a foundation of clear, actionable standards. Strategic learning objectives are not merely academic; they are the roadmap for ensuring every professional at Zentrum24 is prepared to protect product integrity and patient safety. By establishing these measurable goals, we translate high-level policy into the precise execution required for cGMP compliance.

Upon completion of this module, trainees will be able to:

• Define the standardized approach and scope for identifying particulates found during retain inspection activities at the DP-MFG-FACILITY.
• Categorize particulates into three distinct classifications—Intrinsic, Inherent, and Extrinsic—to determine the necessary depth of the impact assessment.
• Differentiate between the primary triggers for particulate inspection, specifically distinguishing between routine Annual Inspections and non-routine Customer Complaint investigations.
• Identify the specific department responsible for each of the three successive levels of identification and the criteria required to achieve a conclusive result.

These objectives ensure that you understand your specific role within the Pharmaceutical Quality System (PQS), where particulate control is a non-negotiable barrier against contamination.

2. WHERE THIS POLICY SITS IN THE QUALITY SYSTEM

In a Good Manufacturing Practice (GMP) environment, documentation follows a strict hierarchy to ensure consistency, traceability, and regulatory alignment. The "Policy" layer is the foundation of this system; it establishes the mandatory "what and why" (the intent and requirements) that governs all lower-level documents. Without the policy’s foundational principles, the technical instructions would lack the authority required for a successful audit.

The documentation hierarchy at DP-MFG-FACILITY is structured as follows:

• Policy (The foundation of intent and "What/Why")
• → SOP (Standard Operating Procedure: The step-by-step "How")
• → Work Instruction (Detailed, task-specific directions)
• → Records (The objective evidence of compliance)

While this policy defines the core principles and levels of identification, the specific step-by-step laboratory actions are found in the SOPs. Note clearly: The provided sources do not specify the exact SOP titles or Work Instruction numbers linked to this policy; these are not covered in current sources. You must master the "what and why" of the policy before you are qualified to perform the "how" in the lab.

3. WHY THIS POLICY MATTERS

Particulate control is one of the most critical aspects of patient safety in sterile manufacturing. Any foreign material in a drug product can lead to adverse events; this policy serves as a protective barrier by ensuring that every particle found in a retain is identified, categorized, and rigorously assessed.

Failure to adhere to these protocols introduces significant risks. As per our impact assessment requirements, Extrinsic particles—those originating from outside the process—carry unique risks that must be evaluated, including:

• Biological risks (e.g., presence of insects).
• Materials of animal origin.
• Potential for leachables or extractables.

Our regulatory standing relies on two primary inspection drivers: the Annual Inspection (routine compliance) and Customer Complaints (non-routine investigations requested by QA). Missing these triggers or failing to follow the identification hierarchy compromises the integrity of the PQS. Adhering to this policy is not just a procedural requirement; it is a direct fulfillment of our mission to deliver safe medicine.

4. KEY TERMS & DEFINITIONS

A shared technical vocabulary is essential to ensure clear communication during deviations and investigations. Precision in terminology prevents the misinterpretation of data that could lead to incorrect risk assessments.